Clinical Immunogenicity Assessment Strategies for Cell & Gene Therapy

Time: 2:30 pm
day: Day 2 Track 2 PM

Details:

  • Discussing LNP based gene therapies
  • Examining Allogenic CART therapies in the context of clinical assessment strategies and cross learning opportunities
  • Clonality in allogenic CART therapies

Speakers: